BRCA2 and pancreatic neoplasm: This hypothesis was tested first in vitro applying a BRCA2 gene knockout (KO) model of the colorectal cancer cell line DLD1 [37] and a BRCA2 gene complementation model of the BRCA2-mutant pancreatic cancer cell line CAPAN1 [38].